AMP Europe 2021: Gene Fusions: An Emerging Target in Cancer Diagnostics and Treatment

Enroll


This is a recording of a session from AMP Europe 2021 Virtual Meeting. Purchase a bundle of 8 sessions from the AMP Europe 2021 Virtual Conference for a significant discount by clicking this link.

Session Description:

Gene fusions have been reported across different types of malignancies and have recently emerged as new targets for cancer therapy. There are several approaches available for fusion detection, including conventional techniques, targeted NGS and high-scale sequencing. This session will discuss new ESMO recommendations on the methods for detection of NTRK and other fusions in clinical practice and will review utility of high scale sequencing (RNA-seq) for detection of fusions.

Objectives
After this session, participants will be able to:
  • Discuss the importance of gene fusions for cancer diagnosis and treatment.
  • Identify the technical issues associated with detection of gene fusions in different sample types.
  • Understand the methodologies for detection of fusions in clinical setting.

Chair: Dr. Sabine Merkelbach-Bruse

Presentations:

  • ESMO Guidelines and TRK Algorithm in Cancer, Dr. Frédérique Penault-Llorca

  • High Scale Sequencing (RNA-Seq) for Fusion Detection, Dr. Felix Sahm


Duration: 90 minutes
Recording Date: June 14, 2021

Last day to purchase: December 31, 2024

There are no CME or CMLE credits available.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.


Enroll